OTCPK:GBGPF - Post by User
Post by
Marginofsafteyon Sep 26, 2017 11:08am
229 Views
Post# 26742368
CanniMed Therapeutics has 56% upside, says Echelon Wealth
CanniMed Therapeutics has 56% upside, says Echelon Wealth https://www.cantechletter.com/2017/09/cannimed-therapeutics-56-upside-says-echelon-wealth/
This company has been hitting on all cylinders including (1) the unexpected increase in facility expansion, (2) its growth ramp up of cannibus oils with dedicated facility ramp up soon, (3) international deals, (4) its production quality control and first mover-advantage with Health Canada (5) M&A space is also ripe, (6) the company has added great executives for its recreational strategy and (7) above average margins due to superior medical branding and focus on cannibus oils.
Continues to fly under the radar as a result of recreational hype that it hasn't played in to the same degree. CMED continues to focus on the results and frankly is delivering.
Accumulate stocks at these levels.
GLTA,
Marginofsaftey